LambrosCChronesMD

PubMed

• 1 citations
  Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study.
  McDaniel, B., Cornet, V., Carroll, J., Chudzik, J., Cochran, J., Guha, S., Lawrence, D., McCue, M., Sarkey, S., Lorenz, B., Chrones, L., Fawver, J.> ;BMC Psychiatry. 2023 Dec 13
• Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with m...
  Subhara Raveendran, Deepshikha Singh, Mary C Burke, Alicia H McAuliffe-Fogarty, Sagar V Parikh, Roger S McIntyre, Anit Roy, Michael Martin, Lambros Chrones, Mark G A O...> ;BMC Psychiatry. 2023 Jun 26
• 3 citations
  Longitudinal study to assess antidepressant treatment patterns and outcomes in individuals with depression in the general population.
  Maurice M Ohayon, Maggie McCue, Andrew Krystal, Katherine J Selzler, Lambros Chrones, Debra Lawrence, Marie-Lise Côté> ;Journal of Affective Disorders. 2023 Jan 15
• 2 citations
  An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study.
  Roger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, Mehala Subramaniapillai, Flora Nasri, Yena Lee, Ben Fehnert, James King, Lambros Chrones, Kevin Kratiuk, Sharif Udd...> ;JMIR Mental Health. 2022 Oct 27
• 3 citations
  Characterizing primary care for patients with major depressive disorder using electronic health records of a US-based healthcare provider.
  Sharon Larson, Andrei Nemoianu, Debra F Lawrence, Melissa A Troup, Michael R Gionfriddo, Haiyan Sun, Faisal Riaz, Eric S Wagner, Lambros Chrones, Maelys Touya, Pousti, B.> ;Journal of Affective Disorders. 2022 Mar 1
• 8 citations
  Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data.
  Maëlys Touya, Debra F Lawrence, Anne Kangethe, Lambros Chrones, Themmi Evangelatos, Michael Polson> ;BMC Psychiatry. 2022 Mar 1
• 3 citations
  Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study.
  Gregory Mattingly, Elizabeth Brunner, Lambros Chrones, Debra F Lawrence, Kenneth Simonsen, Hongye Ren> ;Frontiers in Psychiatry. 2022 Jan 1
• 10 citations
  A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor.
  Max Tsai, Lambros Chrones, Jinhui Xie, Hakop Gevorkyan, Thomas A. Macek> ;Psychopharmacology. 2016 Aug 30
• 101 citations
  The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies
  David S. Baldwin, Lambros Chrones, Ioana Florea, Rebecca Z. Nielsen, George G. Nomikos, William Palo, Elin Heldbo Reines> ;Journal of Psychopharmacology. 2016 Feb 9
• 57 citations
  Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction
  Paula L. Jacobsen, Atul R. Mahableshwarkar, Yinzhong Chen, Lambros Chrones, Anita H. Clayton> ;The Journal of Sexual Medicine. 2015 Oct 1
• Join now to see all